Over the last 12 months, Axsome Therapeutics insiders reported no purchases and 10 sales totaling $46.8M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,664 | $212.19 | $10.5M | -87.3% | plan · 2 tranches |
| Jul 1, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,666 | $240.25 | $11.9M | -87.3% | plan |
| Jun 11, 2026 | JEFFS ROGERD | ▼ Sale | 572 | $247.65 | $142K | -1% | plan · 2 tranches |
| Jun 10, 2026 | Mahony SusanD | ▼ Sale | 600 | $241.7 | $145K | -42% | plan · 2 tranches |
| Jun 10, 2026 | Coleman MarkD | ▼ Sale | 643 | $249 | $160K | -2.1% | plan |
| Jun 9, 2026 | TABUTEAU HERRIOTChief Executive Officer · O·D·10% | ▼ Sale | 49,670 | $241.01 | $12.0M | -87.3% | plan |
| Jun 9, 2026 | Pizzie NickChief Financial Officer · O | ▼ Sale | 33,000 | $240.09 | $7.9M | -43.5% | plan |
| Jun 2, 2026 | Coleman MarkD | ▼ Sale | 5,537 | $223.39 | $1.2M | -15.8% | plan |
| Jun 1, 2026 | Coleman MarkD | ▼ Sale | 6,000 | $230.3 | $1.4M | -14.6% | plan |
| May 29, 2026 | Coleman MarkD | ▼ Sale | 6,000 | $233.46 | $1.4M | -12.7% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AXSM feed.